Metrion Biosciences is a UK-based Contract Research Organization (CRO) focussed on delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, hERG screening, including GLP compliant hERG screening, plus CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. Metrion has also recently expanded its High Throughput Screening capabilities and now offers increased throughput using the Qube and the FLIPR.

Working closely with our collaborators, we also offer an expert integrated drug discovery service. Metrion offers flexible business models according to the scope of each programme, with both fee-for-service and collaborative options available.

Metrion has assembled a team of highly expert and dedicated ion channel screening specialists to support diverse ion channel drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.